Multisystemic Inflammatory Syndrome in Children, A Disease with Too Many Faces: A Single-Center Experience

Alina Grama1,2, Simona Sorana Căinap1,2, Alexandra Mititelu2

  • 1Pediatric Discipline, Department of Mother and Child, Iuliu Hațieganu University of Medicine and Pharmacy, 400177 Cluj-Napoca, Romania.

Journal of Clinical Medicine
|September 23, 2022
PubMed

Insights

Multisystemic inflammatory syndrome in children (MIS-C) linked to SARS-CoV-2 infection presents with diverse severity. Severe MIS-C cases show significant organ dysfunction and require intensive care, with some developing long-term complications.

Area of Science:

  • Pediatric infectious diseases
  • Immunology
  • Critical care medicine

Background:

  • Multisystemic inflammatory syndrome in children (MIS-C) is a rare but severe condition following SARS-CoV-2 infection.
  • The exact mechanisms, risk factors, and disease progression of MIS-C remain incompletely understood.
  • This study addresses the need for detailed clinical descriptions and risk factor analysis of MIS-C in pediatric populations.

Purpose of the Study:

  • To describe the clinical features, treatment strategies, and outcomes of MIS-C in hospitalized children.
  • To identify key risk factors associated with severe forms of MIS-C.
  • To analyze the disease evolution and long-term complications in pediatric MIS-C patients.

Main Methods:

  • A retrospective study was conducted over 13 months (November 2020-December 2021).
  • The study included 34 children diagnosed with MIS-C based on established criteria.
  • Data collected included clinical manifestations, laboratory findings, treatment interventions, and patient outcomes.

Main Results:

  • The cohort included 34 children (mean age 6.8 years) with MIS-C, characterized by fever and organ dysfunction.
  • Over half (55.88%) presented with severe disease, including multiorgan failure and shock.
  • Severe MIS-C cases exhibited significantly higher organ involvement and specific laboratory abnormalities (e.g., hypoalbuminemia, hyponatremia), necessitating aggressive medical support.

Conclusions:

  • MIS-C presents a spectrum from mild to severe forms, posing diagnostic and management challenges for pediatricians.
  • Early recognition and awareness of potential severe evolution and complications are crucial for optimal patient care.
  • The study highlights the critical need for vigilant monitoring and prompt intervention in pediatric patients with MIS-C.
Abstract

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...